ELDER PHARMACEUTICALS LTD.

NSE : NABSE : 532322ISIN CODE : INE975A01015Industry : Pharmaceuticals & DrugsHouse : Elder
BSE38.000 (0 %)
PREV CLOSE ( ) 38.00
OPEN PRICE ( ) 38.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 20547
TODAY'S LOW / HIGH ( )37.10 38.00
52 WK LOW / HIGH ( ) 37.138
NSE
This Company is not listed in NSE
( in Million)
Select year
ParticularsJun2014Jun2013Mar2012Mar2011Mar2010
Profit Before Tax-3652.881071.38915.05810.83587.90
Adjustment6719.231644.771093.28901.42656.14
Changes In working Capital8799.84-2298.52-1640.65-868.80-1518.77
Cash Flow after changes in Working Capital11866.19417.62367.68843.45-274.73
Cash Flow from Operating Activities11754.07165.93147.48657.35-909.94
Cash Flow from Investing Activities-560.52-632.44-1710.99-1506.67-1611.07
Cash Flow from Financing Activities-6761.85-39.10432.612733.931843.08
Net Cash Inflow / Outflow4431.70-505.61-1130.911884.62-677.94
Opening Cash & Cash EquivalentsNANANA786.301464.23
Cash & Cash Equivalent on Amalgamation / Take over / Merger1034.401540.012670.91NANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent5466.101034.401540.012670.91786.30

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.